Sr. Correspondent, Broker Research, Bangalore, India
Saqib's Feed
Oct 15, 2014

U.S. options volume at highest since 2011 as volatility soars

NEW YORK, Oct 15 (Reuters) – Growing concerns about the
economy and markets sent volatility soaring on Wednesday and
pushed trading volume in the U.S. options market to its highest
level in more than three years, as traders moved to hedge their
portfolios on fear of further market gyrations.

The CBOE VIX index – the stock market’s “fear gauge,”
- rose to touch 31.06, its highest level since December 2011,
before pulling back to close at 26.25.

Oct 14, 2014
Oct 13, 2014

U.S. options market set for more downside in stocks

NEW YORK, Oct 13 (Reuters) – Traders in the U.S. equity
options market loaded up on downside protection on Monday by the
greatest margin in more than six years as a third straight day
of steep stock market losses signaled to derivatives players
that there is far more volatility to come.

Trading in puts conveying the right to sell stocks at a set
price in the future exceeded calls that provide a comparable
option to buy them at a later date by a 1.45-to-1 margin. This
so-called put-to-call ratio was the most heavily skewed to puts
since the early days of the financial crisis in March 2008,
according to Interactive Brokers data.

Oct 13, 2014
Oct 13, 2014
Oct 13, 2014
Oct 11, 2014
Oct 10, 2014

More volatility ahead for chipmakers after Microchip warning

NEW YORK (Reuters) – Shares of U.S. chipmakers are expected to remain volatile in coming weeks, options activity showed on Friday, a day after Microchip Technology Inc (MCHP.O: Quote, Profile, Research, Stock Buzz) spooked the market by warning of a broad-based industry downturn.

A number of U.S. semiconductor makers with global operations have in recent weeks suggested various industries, including autos and network equipment, are reducing demand for chips in regions ranging from Asia to Europe.

Oct 9, 2014

Stock option volumes soar for biotechs with Ebola drugs

NEW YORK (Reuters) – The newest twist in the business of trying to capitalize on the outbreak of the Ebola virus is playing out in the U.S. equity options market.

Trading volumes have soared in the stock options of a pair of biotechnology companies thought to have promising treatments for the deadly disease which has claimed the lives of 3,865 people worldwide, according to the World Health Organization.

Oct 9, 2014
    • About Saqib

      "Saqib Ahmed is an options correspondent working with the Markets team in New York. He previously led the Reuters Broker Research team in Bangalore. He joined Reuters in 2009 after graduating from the Asian College of Journalism."
      Joined Reuters:
      English, Hindi, Bengali
    • More from Saqib

    • Contact Saqib

    • Follow Saqib